These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 34381362)
1. CaMKII Inhibition is a Novel Therapeutic Strategy to Prevent Diabetic Cardiomyopathy. Veitch CR; Power AS; Erickson JR Front Pharmacol; 2021; 12():695401. PubMed ID: 34381362 [TBL] [Abstract][Full Text] [Related]
2. CaMKII signaling in heart diseases: Emerging role in diabetic cardiomyopathy. Hegyi B; Bers DM; Bossuyt J J Mol Cell Cardiol; 2019 Feb; 127():246-259. PubMed ID: 30633874 [TBL] [Abstract][Full Text] [Related]
3. Hyperglycemia Acutely Increases Cytosolic Reactive Oxygen Species via Lu S; Liao Z; Lu X; Katschinski DM; Mercola M; Chen J; Heller Brown J; Molkentin JD; Bossuyt J; Bers DM Circ Res; 2020 May; 126(10):e80-e96. PubMed ID: 32134364 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of calcium/calmodulin-dependent kinase II restores contraction and relaxation in isolated cardiac muscle from type 2 diabetic rats. Daniels LJ; Wallace RS; Nicholson OM; Wilson GA; McDonald FJ; Jones PP; Baldi JC; Lamberts RR; Erickson JR Cardiovasc Diabetol; 2018 Jun; 17(1):89. PubMed ID: 29903013 [TBL] [Abstract][Full Text] [Related]
5. Calcium-calmodulin-dependent protein kinase mediates the intracellular signalling pathways of cardiac apoptosis in mice with impaired glucose tolerance. Federico M; Portiansky EL; Sommese L; Alvarado FJ; Blanco PG; Zanuzzi CN; Dedman J; Kaetzel M; Wehrens XHT; Mattiazzi A; Palomeque J J Physiol; 2017 Jun; 595(12):4089-4108. PubMed ID: 28105734 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of CaMKII Activation in the Heart. Erickson JR Front Pharmacol; 2014; 5():59. PubMed ID: 24765077 [TBL] [Abstract][Full Text] [Related]
7. Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy. Beauverger P; Ozoux ML; Bégis G; Glénat V; Briand V; Philippo MC; Daveu C; Tavares G; Roy S; Corbier A; Briand P; Dorchies O; Bauchet AL; Nicolai E; Duclos O; Tamarelle D; Pruniaux MP; Muslin AJ; Janiak P Cardiovasc Res; 2020 Feb; 116(2):329-338. PubMed ID: 31038167 [TBL] [Abstract][Full Text] [Related]
8. CaMKII as a target for arrhythmia suppression. Mustroph J; Neef S; Maier LS Pharmacol Ther; 2017 Aug; 176():22-31. PubMed ID: 27742568 [TBL] [Abstract][Full Text] [Related]
9. All-trans retinoic acid attenuates isoproterenol-induced cardiac dysfunction through Crabp1 to dampen CaMKII activation. Park SW; Nhieu J; Lin YW; Wei LN Eur J Pharmacol; 2019 Sep; 858():172485. PubMed ID: 31238067 [TBL] [Abstract][Full Text] [Related]
11. Role of CaMKII in cardiac arrhythmias. Hund TJ; Mohler PJ Trends Cardiovasc Med; 2015 Jul; 25(5):392-7. PubMed ID: 25577293 [TBL] [Abstract][Full Text] [Related]
12. Activation of CaMKII as a key regulator of reactive oxygen species production in diabetic rat heart. Nishio S; Teshima Y; Takahashi N; Thuc LC; Saito S; Fukui A; Kume O; Fukunaga N; Hara M; Nakagawa M; Saikawa T J Mol Cell Cardiol; 2012 May; 52(5):1103-11. PubMed ID: 22394624 [TBL] [Abstract][Full Text] [Related]
13. A combined CaMKII inhibition and mineralocorticoid receptor antagonism via eplerenone inhibits functional deterioration in chronic pressure overloaded mice. Driessen HE; Fontes MS; van Stuijvenberg L; Brans MA; Goumans MJ; Vos MA; van Veen TA J Cell Mol Med; 2020 Aug; 24(15):8417-8429. PubMed ID: 32573944 [TBL] [Abstract][Full Text] [Related]
15. CaMKII-δ9 Induces Cardiomyocyte Death to Promote Cardiomyopathy and Heart Failure. Zhang M; Zhang J; Zhang W; Hu Q; Jin L; Xie P; Zheng W; Shang H; Zhang Y Front Cardiovasc Med; 2021; 8():820416. PubMed ID: 35127874 [TBL] [Abstract][Full Text] [Related]
16. Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy. Khoo MS; Li J; Singh MV; Yang Y; Kannankeril P; Wu Y; Grueter CE; Guan X; Oddis CV; Zhang R; Mendes L; Ni G; Madu EC; Yang J; Bass M; Gomez RJ; Wadzinski BE; Olson EN; Colbran RJ; Anderson ME Circulation; 2006 Sep; 114(13):1352-9. PubMed ID: 16982937 [TBL] [Abstract][Full Text] [Related]
17. Valsartan improves cardiac function in mice with diabetes mellitus by CaMKII/AngII. Bao SL; Pan J; Sun HX; Liu WT Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5327-5334. PubMed ID: 30178858 [TBL] [Abstract][Full Text] [Related]
18. A role for calcium/calmodulin-dependent protein kinase II in cardiac disease and arrhythmia. Hund TJ; Rudy Y Handb Exp Pharmacol; 2006; (171):201-20. PubMed ID: 16610345 [TBL] [Abstract][Full Text] [Related]
19. Amelioration of mitochondrial dysfunction in heart failure through S-sulfhydration of Ca Wu D; Hu Q; Tan B; Rose P; Zhu D; Zhu YZ Redox Biol; 2018 Oct; 19():250-262. PubMed ID: 30195191 [TBL] [Abstract][Full Text] [Related]